Lataro et al. have demonstrated that donepezil reduces the plasma levels of TNF-α, IL-6, and interferon-γ, thus indicating that acetylcholinesterase inhibition attenuate the development of hypertension in SHRs, probably through anti-inflammatory effects37. This evidence concerns the gene IL6 and Hypertension.